MedPath

Brachytherapy using linked-seed for prostate cancer with one intermediate risk factor -multicenter phase I/II trial

Phase 1
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000011500
Lead Sponsor
Osaka University Graduate School of Medicine, Radiation Oncology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Male
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1) active other cancer 2) uncontrollable diabetes millitus 3) ubable to stop anticoagulation drug 4) significant psycologic disease 5) collagen disease 6) judged as inappropriate by the dedicated physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath